1-3 of 3
Andrew Jarratt
Close
Sort by
Journal Articles

Single-cell multiomics reveal the scale of multilayered adaptations enabling CLL relapse during venetoclax therapy

Rachel Thijssen, Luyi Tian, Mary Ann Anderson, Christoffer Flensburg, Andrew Jarratt, Alexandra L. Garnham, Jafar S. Jabbari, Hongke Peng, Thomas E. Lew, Charis E. Teh, Quentin Gouil, Angela Georgiou, Tania Tan, Tirta M. Djajawi, Constantine S. Tam, John F. Seymour, Piers Blombery, Daniel H.D. Gray, Ian J. Majewski, Matthew E. Ritchie, Andrew W. Roberts, David C.S. Huang
Journal: Blood
Blood (2022) 140 (20): 2127–2141.
https://doi.org/10.1182/blood.2022016040
Published: 2022
Includes: Supplemental data
Journal Articles

The mouse Runx1 + 23 hematopoietic stem cell enhancer confers hematopoietic specificity to both Runx1 promoters

Brief Report
Thomas Bee, Emma L.K. Ashley, Sorrel R.B. Bickley, Andrew Jarratt, Pik-Shan Li, Jackie Sloane-Stanley, Berthold Göttgens, Marella F.T.R. de Bruijn
Journal: Blood
Blood (2009) 113 (21): 5121–5124.
https://doi.org/10.1182/blood-2008-12-193003
Published: 2009
Includes: Supplemental data
Journal Articles

Runx1-mediated hematopoietic stem-cell emergence is controlled by a Gata/Ets/SCL-regulated enhancer

Wade T. Nottingham, Andrew Jarratt, Matthew Burgess, Caroline L. Speck, Jan-Fang Cheng, Shyam Prabhakar, Eddy M. Rubin, Pik-Shan Li, Jackie Sloane-Stanley, John Kong-a-San, Marella F. T. R. de Bruijn
Journal: Blood
Blood (2007) 110 (13): 4188–4197.
https://doi.org/10.1182/blood-2007-07-100883
Published: 2007
Includes: Supplemental data